Studio Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Studio Investment Management's AMGN Position: Q2 2026 in Review
Studio Investment Management reduced its Amgen (AMGN) stake by 0.65% in Q2 2026, selling an estimated $25K and leaving 11,212 shares worth $4.06M. The position accounts for 0.69% of the portfolio, ranked #33.
Studio Investment Management first reported a position in AMGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.2M in Q4 2021. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Studio Investment Management held 11,212 shares of Amgen worth $4.06M as of Q2 2026.
- Studio Investment Management sold 73 Amgen shares in Q2 2026, an estimated $25K.
- Amgen made up 0.69% of Studio Investment Management's portfolio in Q2 2026, its #33 holding.
- Studio Investment Management first reported a position in Amgen in Q3 2021 and has held it in 20 quarters since.
- Studio Investment Management's Amgen position peaked at $4.2M in Q4 2021.
- 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.